NBIX
NBIX
NASDAQ · Biotechnology

Neurocrine Biosciences Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$164.26
-1.80 (-1.08%)
Analyst Consensus
Strong Buy
36
Analysts
Very High
Coverage
Buy 31 86%
Hold 5 14%
Sell 0 0%
Price Target
Analyst Price Target -22.7% upside
Low Target $104.30
Average Target $126.93
High Target $177.55
Current Price $164.26
Current
$164.26
Target
$126.93
$104.30 $126.93 avg $177.55
Scenario Analysis
Bear Case
$104.30
-36.5%
Low target
Base Case
$126.93
-22.7%
Avg target
Bull Case
$177.55
+8.1%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$169.57
-3.1% from high
52-Week Low
$122.14
+34.5% from low
50-Day SMA
$139.44
+17.8% vs SMA
200-Day SMA
$135.94
+20.8% vs SMA
RSI (14)
38.6
Neutral
Target vs 52W High
$126.93
-25.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -36.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.5%